Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2018
Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United StatesRuben Mesa, Ralph V Boccia, Michael R Grunwald, et al.
Haematologica|February 6, 2010
Sex differences in the JAK2 V617F allele burden in chronic myeloproliferative disordersBrady L Stein, Donna M Williams, Nae-Yuh Wang, et al.
Blood|December 24, 2023
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEALAaron T Gerds, Ruben Mesa, John M Burke, et al.
Haematologica|June 30, 2011
Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypesBrady L Stein, Donna M Williams, Christine O'Keefe, et al.
Leukemia & Lymphoma|December 19, 2012
Age-related differences in disease characteristics and clinical outcomes in polycythemia veraBrady L Stein, Santosh Saraf, Urszula Sobol, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Regulatory effects of SKAR in interferon α signaling and its role in the generation of type I IFN responsesBarbara Kroczynska, Swarna Mehrotra, Beata Majchrzak-Kita, et al.
The Journal of Biological Chemistry|January 29, 2014
Critical roles for Rictor/Sin1 complexes in interferon-dependent gene transcription and generation of antiproliferative responsesSurinder Kaur, Barbara Kroczynska, Bhumika Sharma, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 9, 2013
Could hypoxia increase the prevalence of thrombotic complications in polycythemia vera?Maurizio Zangari, Louis Fink, Giulia Tolomelli, et al.
The Journal of Biological Chemistry|July 2, 2013
Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursorsSwarna Mehrotra, Bhumika Sharma, Sonali Joshi, et al.
The Journal of Biological Chemistry|October 18, 2012
Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responsesBhumika Sharma, Sonali Joshi, Antonella Sassano, et al.
Pageof 6